Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Milkbased Infant Formula With Dha And Ara

Research Leaders

8 sponsors active, led by Copenhagen University Hospital, Rigshospitalet

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed3
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Milkbased Infant Formula With Dha And Ara1
  • Comparator Formula Cf1
  • Low Birth Weight And Normal Weight Infants1
  • Milkbased Formula With Dha Ara Prebiotics1
  • Marketed Infant Formula With Dha And Ara1

Active Sponsors

  • Copenhagen University Hospital, Rigshospitalet1
  • Istanbul Medipol University Hospital1
  • Technical University of Denmark1
  • Odense University Hospital1
  • ByHeart1

Top Investigators

Related Conditions

  • Necrotising Enterocolitis1
  • Atresia Bowel1
  • Preterm Infants1
  • Healthy1
  • Low Birth Weight Infants1

Activity Timeline